相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice
Olivier Outteryck et al.
JOURNAL OF NEUROLOGY (2010)
Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study
A. B. Oturai et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
Michael Hutchinson et al.
JOURNAL OF NEUROLOGY (2009)
New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab
Hans-Peter Hartung
LANCET NEUROLOGY (2009)
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
Eva Havrdova et al.
LANCET NEUROLOGY (2009)
The pharmacovigilance program on natalizumab in Italy: 2 years of experience
G. Tedeschi et al.
NEUROLOGICAL SCIENCES (2009)
The incidence and significance of anti-natalizumab antibodies -: Results from AFFIRM and SENTINEL
P. A. Calabresi et al.
NEUROLOGY (2007)
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring
Ludwig Kappos et al.
LANCET NEUROLOGY (2007)
Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
E. R. Dorsey et al.
NEUROLOGY (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
分享论文
